Publication: Compounds that select against the tetracycline resistance efflux pump
Loading...
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Stone, Laura K., Michael Baym, Tami D. Lieberman, Remy Chait, Jon Clardy, and Roy Kishony. 2016. “Compounds that select against the tetracycline resistance efflux pump.” Nature chemical biology 12 (11): 902-904. doi:10.1038/nchembio.2176. http://dx.doi.org/10.1038/nchembio.2176.
Abstract
We developed a competition-based screening strategy to identify compounds that invert the selective advantage of antibiotic resistance. Using our assay, we screened over 19,000 compounds for the ability to select against the TetA tetracycline resistance efflux pump in E. coli and identified two hits: β-thujaplicin and disulfiram. Treating a tetracycline resistant population with β-thujaplicin selects for loss of the resistance gene, enabling an effective second-phase treatment with doxycycline.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service